SH3 Domain Recognition of a Proline-independent Tyrosine-based RKxxYxxY Motif in Immune Cell Adaptor SKAP55
Overview
Molecular Biology
Affiliations
Src-homology 3 (SH3) domains recognize PXXP core motif preceded or followed by positively charged residue(s). Whether SH3 domains recognize motifs other than proline-based sequences is unclear. In this study, we report SH3 domain binding to a novel proline-independent motif in immune cell adaptor SKAP55, which is comprised of two N-terminal lysine and arginine residues followed by two tyrosines (i.e. RKxxYxxY). Domains capable of binding to class I proline motifs bound to the motif, while the class II domains failed to bind. Peptide precipitation, alanine scanning and in vivo co-expression studies demonstrated a requirement for the arginine, lysine and tandem tyrosines of the motif. Two-dimensional NMR analysis of the peptide bound FYN-SH3 domain showed overlap with the binding site of a proline-rich peptide on the charged surface of the SH3 domain, while resonance signals for other residues (W119, W120, Y137) were not perturbed by the RKGDYASY based peptide. Expression of the RKGDYASY peptide potently inhibited TcRzeta/CD3-mediated NF-AT transcription in T cells. Our findings extend the repertoire of SH3 domain binding motifs to include a tyrosine-based motif and demonstrate a regulatory role for this motif in receptor signaling.
A Systematic Compilation of Human SH3 Domains: A Versatile Superfamily in Cellular Signaling.
Mehrabipour M, Kazemein Jasemi N, Dvorsky R, Ahmadian M Cells. 2023; 12(16).
PMID: 37626864 PMC: 10453029. DOI: 10.3390/cells12162054.
Liu C, Raab M, Gui Y, Rudd C Front Immunol. 2023; 14:1192838.
PMID: 37325633 PMC: 10264576. DOI: 10.3389/fimmu.2023.1192838.
Novel Roles of SH2 and SH3 Domains in Lipid Binding.
Sipeki S, Koprivanacz K, Takacs T, Kurilla A, Laszlo L, Vas V Cells. 2021; 10(5).
PMID: 34068055 PMC: 8152464. DOI: 10.3390/cells10051191.
Do polyproline II helix associations modulate biomolecular condensates?.
Mompean M, Oroz J, Laurents D FEBS Open Bio. 2021; 11(9):2390-2399.
PMID: 33934561 PMC: 8409303. DOI: 10.1002/2211-5463.13163.
How the Discovery of the CD4/CD8-p56 Complexes Changed Immunology and Immunotherapy.
Rudd C Front Cell Dev Biol. 2021; 9:626095.
PMID: 33791292 PMC: 8005572. DOI: 10.3389/fcell.2021.626095.